Glycyrrhizic acid restrains airway inflammation and remodeling in asthma via the TGF‑β1/Smad signaling pathway

Yao,Ziping; Fu,Yanling

doi:10.3892/etm.2021.9892

Glycyrrhizic acid restrains airway inflammation and remodeling in asthma via the TGF‑β1/Smad signaling pathway

Authors:
- Ziping Yao
- Yanling Fu
View Affiliations

Affiliations: College of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, P.R. China
Published online on: March 3, 2021 https://doi.org/10.3892/etm.2021.9892
Article Number: 461
Copyright: © Yao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The anti‑inflammatory effects of glycyrrhizic acid (GA) against asthma have previously been reported; however, the underlying molecular mechanism of GA in asthma has not yet been elucidated. Thus, the present study aimed to determine the function and potential molecular mechanism of GA for modulating the transforming growth factor‑β1 (TGF‑β1)/Smad signaling pathway in asthma‑associated airway inflammation and remodeling. In order to study the mechanism of GA on airway inflammation and airway remodeling in asthmatic mice, a mouse model of chronic asthma was constructed. A total of 50 female mice were randomly assigned into five groups (10 mice/group), as follows: Blank group, asthma group, GA group, dexamethasone group and GA + TGF‑β1 group. Hematoxylin and eosin, and Masson staining were performed to assess the airway inflammation and remodeling in mice with ovalbumin (OVA)‑induced asthma. The serum levels of interleukin (IL)‑4, IL‑5, IL‑13 and IL‑17 in mice were assessed via the enzyme‑linked immunosorbent assay. Reverse transcription‑quantitative PCR and western blot analyses were performed to detect the levels of TGF‑β1 and Smads in lung tissues of each group of mice. The results demonstrated that GA and dexamethasone treatment mitigated airway inflammation, inflammatory cell infiltration and airway remolding, with a concomitant decrease in the expression levels of IL‑4, IL‑5, IL‑13 and IL‑17, in mice with OVA‑induced asthma. In addition, the levels of TGF‑β1 and Smad2 notably decreased, while Smad7 expression increased in the GA and dexamethasone groups compared with the asthma group. Furthermore, histopathological morphometry exhibited significantly elevated inflammatory cell infiltration, airway wall and smooth muscle, collagen secretion and inflammatory cytokines in the serum of mice in the GA + TGF‑β1 group compared with the GA group. Taken together, the results of the present study suggest that GA ameliorates airway inflammation and remodeling via the TGF‑β1/Smad signaling pathway in mice with asthma.

View Figures

View References

1	Papi A, Brightling C, Pedersen SE and Reddel HK: Asthma. Lancet. 391:783–800. 2018.PubMed/NCBI View Article : Google Scholar
2	Zhu X, Li Q, Hu G, Wang J, Hu Q, Liu Z, Wu G and Zhong Y: BMS345541 inhibits airway inflammation and epithelialmesenchymal transition in airway remodeling of asthmatic mice. Int J Mol Med. 42:1998–2008. 2018.PubMed/NCBI View Article : Google Scholar
3	Jo A, Lee SH, Kim DY, Hong SJ, Teng MN, Kolliputi N, Lockey RF, Schleimer RP and Cho SH: Mast cell-derived plasminogen activator inhibitor type 1 promotes airway inflammation and remodeling in a murine model of asthma. J Allergy Clin Immunol. 142:294–297.e5. 2018.PubMed/NCBI View Article : Google Scholar
4	Gupta A, Chakraborty S and Agrawal A: Molecular and Genomic Basis of Bronchial Asthma. In: Clinical Molecular Medicine. Academic Press, pp353-366, 2020.
5	Wu P, Xu B, Shen A, He Z, Zhang CJ, Ming WK and Shen K: The economic burden of medical treatment of children with asthma in China. BMC Pediatr. 20(386)2020.PubMed/NCBI View Article : Google Scholar
6	Bao Z, Zhang P, Yao Y, Lu G, Tong Z, Yan B, Tu L, Yang G and Zhou J: Deguelin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice. Int J Biol Sci. 13:492–504. 2017.PubMed/NCBI View Article : Google Scholar
7	Cho IH, Choi YJ, Gong JH, Shin D, Kang MK and Kang YH: Astragalin inhibits autophagy-associated airway epithelial fibrosis. Respir Res. 16(51)2015.PubMed/NCBI View Article : Google Scholar
8	Li Y, Wang H and Yang X: Effects of catalpol on bronchial asthma and its relationship with cytokines. J Cell Biochem. 120:8992–8998. 2019.PubMed/NCBI View Article : Google Scholar
9	Sung JE, Lee HA, Kim JE, Yun WB, An BS, Yang SY, Kim DS, Lee CY, Lee HS, Bae CJ and Hwang DY: Saponin-enriched extract of Asparagus cochinchinensis alleviates airway inflammation and remodeling in ovalbumin-induced asthma model. Int J Mol Med. 40:1365–1376. 2017.PubMed/NCBI View Article : Google Scholar
10	Fouladi S, Masjedi M, Ghasemi R, Hakemi MG and Eskandari N: The in vitro impact of glycyrrhizic acid on CD4⁺ T lymphocytes through OX40 receptor in the patients with allergic rhinitis. Inflammation. 41:1690–1701. 2018.PubMed/NCBI View Article : Google Scholar
11	Qu L, Chen C, He W, Chen Y, Li Y, Wen Y, Zhou S, Jiang Y, Yang X, Zhang R and Shen L: Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. Am J Transl Res. 11:2042–2055. 2019.PubMed/NCBI
12	Su X, Wu L, Hu M, Dong W, Xu M and Zhang P: Glycyrrhizic acid: A promising carrier material for anticancer therapy. Biomed Pharmacother. 95:670–678. 2017.PubMed/NCBI View Article : Google Scholar
13	Gao L, Tang H, He H, Liu J, Mao J, Ji H, Lin H and Wu T: Glycyrrhizic acid alleviates bleomycin-induced pulmonary fibrosis in rats. Front Pharmacol. 6(215)2015.PubMed/NCBI View Article : Google Scholar
14	Wu Q, Tang Y, Hu X, Wang Q, Lei W, Zhou L and Huang J: Regulation of Th1/Th2 balance through OX40/OX40L signalling by glycyrrhizic acid in a murine model of asthma. Respirology. 21:102–111. 2016.PubMed/NCBI View Article : Google Scholar
15	Liu YD, Sun X, Zhang Y, Wu HJ, Wang H and Yang R: Protocatechuic acid inhibits TGF-beta1-induced proliferation and migration of human airway smooth muscle cells. J Pharmacol Sci. 139:9–14. 2019.PubMed/NCBI View Article : Google Scholar
16	Ojiaku CA, Yoo EJ and Panettieri RA Jr: Transforming growth factor β1 function in airway remodeling and hyperresponsiveness. The missing link? Am J Respir Cell Mol Biol. 56:432–442. 2017.PubMed/NCBI View Article : Google Scholar
17	Macias MJ, Martin-Malpartida P and Massague J: Structural determinants of Smad function in TGF-β signaling. Trends Biochem Sci. 40:296–308. 2015.PubMed/NCBI View Article : Google Scholar
18	van der Kraan PM: Differential role of transforming growth factor-beta in an osteoarthritic or a healthy joint. J Bone Metab. 25:65–72. 2018.PubMed/NCBI View Article : Google Scholar
19	Ogden BE, Pang William W, Agui T and Lee BH: Laboratory animal laws, regulations, guidelines and standards in China Mainland, Japan, and Korea. ILAR J. 57:301–311. 2016.PubMed/NCBI View Article : Google Scholar
20	Shi YX, Dai X, Wang LJ, et al: Effect of ligustrazine on airway inflammation and airway remodeling in asthmatic mice by regulating TGF-β1/Smad signaling pathway. Drugs Clinic. 1:20–26. 2019.
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
22	Nakagami Y, Favoreto S Jr, Zhen G, Park SW, Nguyenvu LT, Kuperman DA, Dolganov GM, Huang X, Boushey HA, Avila PC and Erle DJ: The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model. J Immunol. 181:2203–2210. 2008.PubMed/NCBI View Article : Google Scholar
23	Blasi F, Bettoncelli G, Canonica GW, Centanni S, Crimi N, DiMaria G, Gasparini S, Gentili G, Girbino G, Mereu C, et al: The management of asthma in the phenotype and biomarker era: The proposal of a new diagnostic-therapeutic model. J Asthma. 53:665–667. 2016.PubMed/NCBI View Article : Google Scholar
24	Liang B, Guo XL, Jin J, Ma YC and Feng ZQ: Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury. World J Gastroenterol. 21:5271–5280. 2015.PubMed/NCBI View Article : Google Scholar
25	Zhao H, Liu Z, Shen H, Jin S and Zhang S: Glycyrrhizic acid pretreatment prevents sepsis-induced acute kidney injury via suppressing inflammation, apoptosis and oxidative stress. Eur J Pharmacol. 781:92–99. 2016.PubMed/NCBI View Article : Google Scholar
26	Zhao H, Zhao M, Wang Y, Li F and Zhang Z: Glycyrrhizic acid prevents sepsis-induced acute lung injury and mortality in rats. J Histochem Cytochem. 64:125–137. 2016.PubMed/NCBI View Article : Google Scholar
27	Tang X, Nian H, Li X, Yang Y, Wang X, Xu L, Shi H, Yang X and Liu R: Effects of the combined extracts of Herba epimedii and Fructus Ligustrilucidi on airway remodeling in the asthmatic rats with the treatment of budesonide. BMC Complement Altern Med. 17(380)2017.PubMed/NCBI View Article : Google Scholar
28	Pang H, Huang T, Song J, Li D, Zhao Y and Ma X: Inhibiting HMGB1 with glycyrrhizic acid protects brain injury after DAI via its anti-inflammatory effect. Mediators Inflamm. 2016(4569521)2016.PubMed/NCBI View Article : Google Scholar
29	Yu JY, Ha JY, Kim KM, Jung YS, Jung JC and Oh S: Anti-inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules. 20:13041–13054. 2015.PubMed/NCBI View Article : Google Scholar
30	Fouladi S, Masjedi M, Ganjalikhani Hakemi M and Eskandari N: The review of in vitro and in vivo studies over the glycyrrhizic acid as natural remedy option for treatment of allergic asthma. Iran J Allergy Asthma Immunol. 18:1–11. 2019.PubMed/NCBI
31	Wang C, Zheng M, Choi Y, Jiang J, Li L, Li J, Xu C, Xian Z, Li Y, Piao H, et al: Cryptotanshinone attenuates airway remodeling by inhibiting crosstalk between tumor necrosis factor-like weak inducer of apoptosis and transforming growth factor beta 1 signaling pathways in asthma. Front Pharmacol. 10(1338)2019.PubMed/NCBI View Article : Google Scholar
32	Lee HY, Kim IK, Yoon HK, Kwon SS, Rhee CK and Lee SY: Inhibitory effects of resveratrol on airway remodeling by transforming growth factor-beta/Smad signaling pathway in chronic asthma model. Allergy Asthma Immunol Res. 9:25–34. 2017.PubMed/NCBI View Article : Google Scholar
33	Qu ZH, Yang ZC, Chen L, Lv ZD, Yi MJ and Ran N: Inhibition airway remodeling and transforming growth factor-β1/Smad signaling pathway by astragalus extract in asthmatic mice. Int J Mol Med. 29:564–568. 2012.PubMed/NCBI View Article : Google Scholar
34	Jeon WY, Shin IS, Shin HK, Jin SE and Lee MY: Aqueous extract of Gumiganghwal-tang, a traditional herbal medicine, reduces pulmonary fibrosis by transforming growth factor-β1/Smad signaling pathway in murine model of chronic asthma. PLoS One. 11(e0164833)2016.PubMed/NCBI View Article : Google Scholar
35	Feng Y, Yang C, Yang W and Jiang T: Effect of dexamethasone on TGF-β1/Smad3 signalling pathway in airway remodelling model of asthmatic rats. J Coll Physicians Surg Pak. 29:537–540. 2019.PubMed/NCBI View Article : Google Scholar
36	Wang J, Li HY, Wang HS and Su ZB: MicroRNA-485 modulates the TGF-β/Smads signaling pathway in chronic asthmatic mice by targeting Smurf2. Cell Physiol Biochem. 51:692–710. 2018.PubMed/NCBI View Article : Google Scholar
37	Chen L, Yang T, Lu DW, Zhao H, Feng YL, Chen H, Chen DQ, Vaziri ND and Zhao YY: Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother. 101:670–681. 2018.PubMed/NCBI View Article : Google Scholar
38	Hu HH, Chen DQ, Wang YN, Feng YL, Cao G, Vaziri ND and Zhao YY: New insights into TGF-β/Smad signaling in tissue fibrosis. Chem Biol Interact. 292:76–83. 2018.PubMed/NCBI View Article : Google Scholar
39	Walton KL, Johnson KE and Harrison CA: Targeting TGF-β mediated SMAD signaling for the prevention of fibrosis. Front Pharmacol. 8(461)2017.PubMed/NCBI View Article : Google Scholar
40	Briones-Orta MA, Tecalco-Cruz AC, Sosa-Garrocho M, Caligaris C and Macias-Silva M: Inhibitory Smad7: Emerging roles in health and disease. Curr Mol Pharmacol. 4:141–153. 2011.PubMed/NCBI
41	Sugiura H, Liu X, Duan F, Kawasaki S, Togo S, Kamio K, Wang XQ, Mao L, Ahn Y, Ertl RF, et al: Cultured lung fibroblasts from ovalbumin-challenged ‘asthmatic’ mice differ functionally from normal. Am J Respir Cell Mol Biol. 37:424–430. 2007.PubMed/NCBI View Article : Google Scholar